feed,title,long_url,short_url
MedRxiv,"Lack of effectiveness of Bebtelovimab Monoclonal Antibody Among High-Risk Patients with SARS-Cov-2 Omicron During BA.2, BA.2.12.1 and BA.5 Subvariants Dominated Era",https://medrxiv.org/cgi/content/short/2022.12.06.22283183v1?rss=1,https://da.gd/O1HoZ
